Wave Life Sciences Ltd. (WVE) concluded trading on Wednesday at a closing price of $6.29, with 6.07 million shares of worth about $38.17 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 41.35% during that period and on Wednesday the price saw a gain of about 31.32%. Currently the company’s common shares owned by public are about 86.92M shares, out of which, 85.70M shares are available for trading.
Stock saw a price change of 23.33% in past 5 days and over the past one month there was a price change of 62.53%. Year-to-date (YTD), WVE shares are showing a performance of 24.55% which increased to 49.76% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.15 but also hit the highest price of $6.94 during that period. The average intraday trading volume for Wave Life Sciences Ltd. shares is 891.74K. The stock is currently trading 45.87% above its 20-day simple moving average (SMA20), while that difference is up 37.17% for SMA50 and it goes to 33.64% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wave Life Sciences Ltd. (NASDAQ: WVE) currently have 86.92M outstanding shares and institutions hold larger chunk of about 70.49% of that.
The stock has a current market capitalization of $748.57M and its 3Y-monthly beta is at -1.16. It has posted earnings per share of -$0.87 in the same period. It has Quick Ratio of 1.59. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for WVE, volatility over the week remained 12.65% while standing at 8.21% over the month.
Analysts are in expectations that Wave Life Sciences Ltd. (WVE) stock would likely to be making an EPS of -$0.23 in the current quarter, while forecast for next quarter EPS is -$0.2 and it is -$0.95 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.43 which is $0.02 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.47 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -65.56% while it is estimated to decrease by -25.95% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Leerink Partners on December 19, 2023 offering an Outperform rating for the stock and assigned a target price range of between $5 and $12 to it. Coverage by Raymond James stated Wave Life Sciences Ltd. (WVE) stock as an Outperform in their note to investors on July 05, 2023, suggesting a price target of $7 for the stock. On May 24, 2023, Jefferies Downgrade their recommendations, while on December 15, 2020, H.C. Wainwright Resumed their ratings for the stock with a price target of $20. Stock get a Sector perform rating from RBC Capital Mkts on October 23, 2020.
